Filing Flows › Comparisons › SRTA vs DCGO
Strata Critical Medical vs DocGo: SRTA and DCGO compared
Strata Critical Medical is the larger company: $74.1M of revenue in its latest quarter (Q3 2026) against $73.4M for DocGo (Q3 2026). Strata Critical Medical is growing faster (+50% against +4% a year earlier). Strata Critical Medical is more profitable, with an operating margin of -5.2% against -23.5%.
Where the money goes: SRTA and DCGO
Strata Critical Medical (SRTA) · Q3 2026
Strata Critical Medical, Q3 2026: revenue $74.1M (+50% year over year), operating margin -5.2%, net loss $7.6M, operating cash flow $9.5M. The chart follows the revenue to costs, profit and cash.
DocGo (DCGO) · Q3 2026
DocGo, Q3 2026: revenue $73.4M (+4% year over year), operating margin -23.5%, net loss $18.3M, operating cash flow −$3.6M. The chart follows the revenue to costs, profit and cash.
| Strata Critical Medical (SRTA) | DocGo (DCGO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $74.1M | $73.4M |
| Revenue growth, Y/Y | +50% | +4% |
| Operating margin | -5.2% | -23.5% |
| Net earnings | −$7.6M | −$18.3M |
| Net margin | -10.3% | -24.9% |
| Operating cash flow | $9.5M | −$3.6M |
| Free cash flow | $8.6M | — |
Where the revenue comes from
Strata Critical Medical
- Logistics: $44.9M (61%)
- Clinical: $29.2M (39%)
DocGo
- Transportation Services: $53.3M (73%)
- Mobile Health Services: $20.2M (27%)
Questions
Which is bigger, Strata Critical Medical or DocGo?
Strata Critical Medical is the larger company: $74.1M of revenue in its latest quarter (Q3 2026) against $73.4M for DocGo (Q3 2026).
Is Strata Critical Medical or DocGo growing faster?
Strata Critical Medical is growing faster (+50% against +4% a year earlier).
Which is more profitable, Strata Critical Medical or DocGo?
Strata Critical Medical is more profitable, with an operating margin of -5.2% against -23.5%.
More: Strata Critical Medical earnings · how Strata Critical Medical makes money · DocGo earnings · how DocGo makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.